Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: A systematic review

Neurourology and Urodynamics

Volumn 32, Issue 3, 2013, Pages 206-214

  Moossdorff Steinhauser, Heidi F A ^a   Berghmans, Bary ^b  

^a Fysio Papendrecht   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

electric stimulation; neuromodulation; overactive; review; tibial nerve; urgency; urinary incontinence

Indexed keywords

OXYBUTYNIN; TOLTERODINE;

BLEEDING; COHORT ANALYSIS; EMBASE; HEADACHE; HEMATURIA; HUMAN; INCONTINENCE; LEG CRAMP; MEDLINE; NERVE STIMULATION; OBSERVATIONAL STUDY; OVERACTIVE BLADDER; PAIN; PERCUTANEOUS TIBIAL NERVE STIMULATION; PROSPECTIVE STUDY; QUALITATIVE ANALYSIS; REVIEW; SHAM PROCEDURE; SWELLING; SYSTEMATIC REVIEW; URINE INCONTINENCE;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; CHOLINERGIC ANTAGONISTS; CLINICAL TRIALS AS TOPIC; CRESOLS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NOCTURNAL ENURESIS; PHENYLPROPANOLAMINE; TIBIAL NERVE; TIME FACTORS; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URODYNAMICS; YOUNG ADULT;

EID: 84875382368     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.22296     Document Type: Review

References (48)

1. Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29: 4-20.
2. Wang Y, Xu K, Hu H, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn 2011; 30: 1448-55.
3. Milsom I, Abrams P, Cardozo L, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study BJU Int 2001; 87: 760-6.
4. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study. Eur Urol 2006; 50: 1306-14; discussion 1314-1315.
5. Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327-36.
6. Ganz ML, Smalarz AM, Krupski TL, et al. Economic costs of overactive bladder in the United States. Urology 2010; 75: 526-32; 532.e1-8.
7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: Results from the EPIC study. BJU Int 2008; 101: 1388-95.
8. Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29: 213-40.
9. van Kerrebroeck PEV, van Voskuilen AC, Heesakkers JPFA, et al. Results: of sacral neuromodulation therapy for urinary voiding dysfunction: Outcomes of a prospective, worldwide clinical study. J Urol 2007; 178: 2029-34.
10. White WM, Mobley JD III, Doggweiler R, et al. Incidence and predictors of complications with sacral neuromodulation. Urology. 2009; 73: 731-5.
11. Ozdedeli S, Karapolat H, Akkoc Y,. Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: A randomized controlled study. Clin Rehabil 2010; 24: 342-51.
12. Yamanishi T, Yasuda K, Sakakibara R, et al. Randomized, double-blind study of electrical stimulation for urinary incontinence due to detrusor overactivity. Urology. 2000; 55: 353-7.
13. Cooperberg MR, Stoller ML,. Percutaneous neuromodulation. Urol Clin North Am 2005; 32: 71-8; vii.
14. Stoller ML,. Afferent nerve stimulation for pelvic floor dysfunction. Eur Urol 1999; 35: 132.
15. Peters KM, Macdiarmid SA, Wooldridge LS, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: Results from the overactive bladder innovative therapy trial. J. Urol. 2009; 182: 1055-61.
16. van Balken MR, Vandoninck V, Gisolf KW, et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 2001; 166: 914-8.
17. Maher CG, Sherrington C, Herbert RD, et al. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phy Ther 2003; 83: 713-21.
18. Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-41.
19. Van Peppen RPS, Kwakkel G, Wood-Dauphinee S, et al. The impact of physical therapy on functional outcomes after stroke: What's the evidence? Clin Rehabil 2004; 18: 833-62.
20. Wells G, Shea B, O'Connel D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis [Internet]. [geciteerd 2010 apr 14]. Available van: http://ohri.ca/programs/ clinicalepidemiology/oxford.htm
21. The Cochrane Collaborative Review Group on HIV infection and AIDS. Editorial Policy: Inclusion and Appraisal of Experimental and Non-experimental (Observational) studies [Internet]. [geciteerd 2010 apr 16]. Available van: http;//www.igh.org/Cochrane
22. van Tulder MW, Cherkin DC, Berman B, et al. The effectiveness of acupuncture in the management of acute and chronic low back pain. A systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine. 1999; 24: 1113-23.
23. Steultjens EMJ, Dekker J, Bouter LM, et al. Occupational therapy for stroke patients: A systematic review. Stroke. 2003; 34: 676-87.
24. Bellette PO, Rodrigues-Palma PC, Hermann V, et al. Posterior tibial nerve stimulation in the management of overactive bladder: A prospective and controlled study. Actas Urol Esp 2009; 33: 58-63.
25. Congregado Ruiz B, Pena Outeiriño XM, Campoy Martínez P, et al. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol 2004; 45: 65-9.
26. Klingler HC, Pycha A, Schmidbauer J, et al. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: A urodynamic-based study. Urology 2000; 56: 766-71.
27. Vandoninck V, Van Balken MR, Finazzi Agrõ E, et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn 2003; 22: 17-23.
28. van der Pal F, van Balken MR, Heesakkers JP, et al. Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation. BJU Int 2006; 97: 113-6.
29. Karademir K, Baykal K, Sen B, et al. A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation. Scand J Urol Nephrol 2005; 39: 230-3.
30. Peters KM, Carrico DJ, Perez-Marrero RA, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: Results from the SUmiT trial. J Urol 2010; 183: 1438-43.
31. Finazzi-Agrò E, Petta F, Sciobica F, et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: A randomized, double-blind, placebo controlled trial. J Urol 2010; 184: 2001-6.
32. Govier FE, Litwiller S, Nitti V, et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: Results of a multicenter study. J Urol 2001; 165: 1193-8.
33. Vandoninck V, van Balken MR, Finazzi Agrò E, et al. Posterior tibial nerve stimulation in the treatment of voiding dysfunction: Urodynamic data. Neurourol Urodyn 2004; 23: 246-51.
34. Nuhǒlu B, Fidan V, Ayyildiz A, et al. Stoller afferent nerve stimulation in woman with therapy resistant over active bladder: A 1-year follow up. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17: 204-7.
35. Yoong W, Ridout AE, Damodaram M, et al. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: Outcomes following a shortened 6-week protocol. BJU Int 2010; 106: 1673-6.
36. Vandoninck V, van Balken MR, Finazzi Agrò E, et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: Urodynamic data. Neurourol Urodyn 2003; 22: 227-32.
37. Levin PJ, Wu JM, Kawasaki A, et al. The efficacy of posterior tibial nerve stimulation for the treatment of overactive bladder in women: A systematic review. International urogynecology journal [Internet]. 2012 mrt 13 [geciteerd 2012 mei 17]; Available van: http://www.ncbi.nlm.nih.gov/pubmed/22411208
38. Burton C, Sajja A, Latthe PM,. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: A systematic review and meta-analysis. Neurourology and urodynamics [Internet]. 2012 mei 11 [geciteerd 2012 mei 17]; Available van: http://www.ncbi.nlm.nih.gov/pubmed/22581511
39. Portney LG, Watkins MP,. Foundations of clinical research 3rd edition. Upper Saddle River, NJ, USA: Pearson Education, Inc.; 2009.
40. Hyman MJ, Groutz A, Blaivas JG,. Detrusor instability in men: Correlation of lower urinary tract symptoms with urodynamic findings. J Urol 2001; 166: 550-2; discussion 553.
41. Mattiasson A,. Characterisation of lower urinary tract disorders: A new view. Neurourol Urodyn 2001; 20: 601-21.
42. de Boer TA, Slieker-ten Hove MCP, Burger CW, et al. The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population. Int Urogynecol J 2011; 22: 569-75.
43. de Boer TA, Salvatore S, Cardozo L, et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn 2010; 29: 30-9.
44. Holmgren C, Nilsson S, Lanner L, et al. Frequency of de novo urgency in 463 women who had undergone the tension-free vaginal tape (TVT) procedure for genuine stress urinary incontinence-A long-term follow-up. Eur J Obstet Gynecol Reprod Biol 2007; 132: 121-5.
45. Zhang W, Song Y, He X, et al. Prevalence and risk factors of overactive bladder syndrome in Fuzhou Chinese women. Neurourol Urodyn 2006; 25: 717-21.
46. Jeong SJ, Lee SC, Jeong CW, et al. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity. International urogynecology journal [Internet]. 2012 mei 16 [geciteerd 2012 jun 4]; Available van: http://www.ncbi.nlm.nih.gov/pubmed/ 22588142
47. Bosch JLHR, Cardozo L, Hashim H, et al. Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol Urodyn 2011; 30: 735-40.
48. MacDiarmid SA, Peters KM, Shobeiri SA, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 2010; 183: 234-40.